Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1968 2
1969 1
1970 1
1972 2
1973 1
1974 1
1975 3
1976 2
1977 4
1978 4
1979 3
1980 4
1981 2
1985 2
1986 6
1987 5
1988 3
1989 5
1990 8
1991 1
1992 3
1993 3
1994 3
1995 2
1996 4
1997 3
1998 2
1999 8
2000 6
2001 3
2002 7
2003 5
2004 1
2005 1
2006 5
2007 2
2008 3
2009 4
2010 11
2011 7
2012 3
2013 8
2014 6
2015 4
2016 5
2017 3
2018 3
2019 3
2020 7
2021 2
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
Kopetz S, Grothey A, Yaeger R, Van Cutsem E, Desai J, Yoshino T, Wasan H, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Pfeiffer P, Orlov S, Lonardi S, Elez E, Kim TW, Schellens JHM, Guo C, Krishnan A, Dekervel J, Morris V, Calvo Ferrandiz A, Tarpgaard LS, Braun M, Gollerkeri A, Keir C, Maharry K, Pickard M, Christy-Bittel J, Anderson L, Sandor V, Tabernero J. Kopetz S, et al. Among authors: pickard m. N Engl J Med. 2019 Oct 24;381(17):1632-1643. doi: 10.1056/NEJMoa1908075. Epub 2019 Sep 30. N Engl J Med. 2019. PMID: 31566309 Clinical Trial.
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.
Dummer R, Ascierto PA, Gogas HJ, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, Chiarion-Sileni V, Dutriaux C, de Groot JWB, Yamazaki N, Loquai C, Moutouh-de Parseval LA, Pickard MD, Sandor V, Robert C, Flaherty KT. Dummer R, et al. Among authors: pickard md. Lancet Oncol. 2018 May;19(5):603-615. doi: 10.1016/S1470-2045(18)30142-6. Epub 2018 Mar 21. Lancet Oncol. 2018. PMID: 29573941 Clinical Trial.
Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma.
Ascierto PA, Dummer R, Gogas HJ, Flaherty KT, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, de Groot JWB, Loquai C, Gollerkeri A, Pickard MD, Robert C. Ascierto PA, et al. Among authors: pickard md. Eur J Cancer. 2020 Feb;126:33-44. doi: 10.1016/j.ejca.2019.11.016. Epub 2020 Jan 2. Eur J Cancer. 2020. PMID: 31901705 Free article. Clinical Trial.
Prostate Biopsy Processing.
Murugan P, Shukla D, Morocho J, Smith D, Sciacca D, Pickard M, Wahlsten M, Gunderson A, Konety B, Khalifa MA, Warlick C. Murugan P, et al. Among authors: pickard m. Am J Clin Pathol. 2019 Nov 4;152(6):757-765. doi: 10.1093/ajcp/aqz101. Am J Clin Pathol. 2019. PMID: 31433833
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.
Dummer R, Ascierto PA, Gogas HJ, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, Chiarion Sileni V, Dutriaux C, de Groot JWB, Yamazaki N, Loquai C, Moutouh-de Parseval LA, Pickard MD, Sandor V, Robert C, Flaherty KT. Dummer R, et al. Among authors: pickard md. Lancet Oncol. 2018 Oct;19(10):1315-1327. doi: 10.1016/S1470-2045(18)30497-2. Epub 2018 Sep 12. Lancet Oncol. 2018. PMID: 30219628 Clinical Trial.
Attitudes of care staff towards video consultations.
Shadwell R, Hemmings C, Pickard M. Shadwell R, et al. Among authors: pickard m. BJPsych Bull. 2020 Oct;44(5):222-223. doi: 10.1192/bjb.2020.91. BJPsych Bull. 2020. PMID: 32981559 Free PMC article. No abstract available.
Role of the pharmacist in childhood immunizations.
Hoeben BJ, Dennis MS, Bachman RL, Bhargava M, Pickard ME, Sokol KM, Vu L, Rovers JP. Hoeben BJ, et al. Among authors: pickard me. J Am Pharm Assoc (Wash). 1997 Sep-Oct;NS37(5):557-62. doi: 10.1016/s1086-5802(16)30243-1. J Am Pharm Assoc (Wash). 1997. PMID: 9479408 Review.
Transport of thyroid hormones to target tissues.
Ekins RP, Sinha AK, Pickard MR, Evans IM, al Yatama F. Ekins RP, et al. Among authors: pickard mr. Acta Med Austriaca. 1994;21(2):26-34. Acta Med Austriaca. 1994. PMID: 7998479 Review.
182 results